We Are
A clinical biotech creating tomorrow’s therapies from today’s patient stories.
News & Events
Get up to speed with our latest news.
Drug Development
ULTRA - PURE CANNABINOIDS
Powered By Real World Evidence
Novel Formulation | Medical Indication | Dose Optimisation | Safety Trials | Pivotal Trials | Approval | |
|---|---|---|---|---|---|---|
EMD-RX5Over the Counter | Psychological Distress | |||||
EMD-RX5Over the Counter | Irritable Bowel Syndrome | |||||
EMD-RX7Prescription | Multiple Medical Conditions | |||||
EMD-RX9Prescription | Multiple Medical Conditions | |||||
New Drug Discovery
MDMA - LIKE MEDICINE PROGRAMS
Ongoing Library Expansion
Program | Medical Indication | Discovery | Pre-Clinical | Phase 1 | Pivotal Trials | Approval |
|---|---|---|---|---|---|---|
Program 01HIGHER POTENCY MDMA | e.g. Drug-assisted psychotherapy | |||||
Program 02SELECTED BRAIN TARGETS | e.g. Parkinson's | |||||
Program 03SELECTED NON-BRAIN TARGETS | e.g. Fibrotic Disease | |||||
Innovation
Technology | Description | Concept | Design | Submission | Approval | Launch |
|---|---|---|---|---|---|---|
OPENLYREMOTE HEALTH TRACKER | Vital Signs Tracked Via Smartphone Camera | CLASS 2A MEDICAL DEVICE | ||||
Pax Centre
Aspen
PsychoGenics
UWA
NIH
Palantir
Institute for Respiratory Health
For Investors
Ours is a collaborative vision and venture. We’re bringing people and partners together for the greater good: patients, clinicians, researchers, medical innovators and, of course, investors.
0
% FDA approvals where real-world evidence (RWE) was provided, and growing.
0
+ Unique data points collected per patient.
$
0
T USD Trillion USD cost of chronic disease and mental health per year in the US.